<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>PR.com Press Releases: The Peptide App News</title>
		<link>https://www.PR.com/</link>
		<description>Latest news releases from PR.com for The Peptide App.</description>
		<lastBuildDate>Wed, 26 Aug 2026 15:58:22 -0400</lastBuildDate>
		<copyright>&#169; 2026 PR.com</copyright>
		<ttl>60</ttl>
		<language>en-us</language>
		<image>
			<url>https://www.PR.com/images/logo_white.jpg</url>
			<title>PR.com Press Releases: The Peptide App News</title>
			<link>https://www.PR.com/</link>
			<width>68</width>
			<height>69</height>
			<description>PR.com provides press release distribution, and is a unique directory of businesses, products and services. Find full company profiles.</description>
		</image>
		<atom:link href="https://www.pr.com/rss/press-releases-2/593235.xml" rel="self" type="application/rss+xml" />
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/977543</guid>
			<title>The Peptide App Opens Public COA Evidence Index with 5,225 Documents</title>
			<pubDate>Wed, 26 Aug 2026 12:45:45 -0400</pubDate>
			<description>The Peptide App launched a free public COA Evidence Index containing 5,225 documents, along with a label-first reconstitution calculator. The launch addresses a fast-changing online peptide market: 60 of 82 storefront domains with available registration dates in the app’s current vendor sample were registered in 2024 or later. The index helps people inspect testing records, sources, and limitations without treating a [PR.com]</description>
			<link>https://www.pr.com/press-release/977543</link>
			<dc:creator>The Peptide App</dc:creator>
		</item>
	</channel>
</rss>